Reporting Manager
Caisse des depots et consignations
Symbol
IPHA
Shares outstanding
92,651,000 shares
Disclosed Ownership
7,319,429 shares
Ownership
7.9%
Form type
SCHEDULE 13D/A
Filing time
07 May 2025, 16:02:17 UTC
Date of event
25 Apr 2025

Sponsored

Quoteable Key Fact

"Bpifrance Participations SA disclosed 7.9% ownership in Innate Pharma SA Ordinary Shares, nominal value EUR0.05 per share (IPHA) on 25 Apr 2025."

Quick Takeaways

  • Bpifrance Participations SA filed SCHEDULE 13D/A for Innate Pharma SA Ordinary Shares, nominal value EUR0.05 per share (IPHA).
  • Disclosed ownership: 7.9%.
  • Date of event: 25 Apr 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 07 May 2025, 16:02.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bpifrance Participations S.A. 6.9% 6,389,406 0 6,389,406 Sophie Paquin Director of Legal Affairs 0001581835
CDC Croissance S.A. 1% 930,023 0 930,023 Aude de Lardemelle Executive Director
Caisse des depots et consignations 7.9% 7,319,429 0 7,319,429 Laurence Giraudon Chief Operating Officer, Finance and Operations Department, Asset Management Division 0001056947
EPIC Bpifrance 6.9% 6,389,406 0 6,389,406 Sophie Paquin Director of Legal Affairs
Bpifrance S.A. 6.9% 6,389,406 0 6,389,406 Boubakar Dione Group Director of Legal Affairs 0001731118